Using millions of longitudinal high quality imaging scans , Zebra-med has been developing a deep learning engine that can automatically detect various medical findings in imaging scans. Current capabilities include automatic detection of liver, lung, cardiovascular and bone disease, and new capabilities are constantly being released – covering breast cancer, lung cancer, brain trauma, hypertension, and other clinical areas. Zebra’s findings are integrated into PACS and RIS systems, allowing radiologists to seamlessly include them in their reading and reporting workflow. This automated assistance contributes to more comprehensive, quantitative and consistent reporting, improving the output of radiologists and contributing to overall improved patient care. The company’s analytics engine is deployed at over 50 hospitals globally, and has analyzed more than 1M patient scans to date.
“With this new model, we hope to facilitate adoption globally, especially in countries where access to radiology is difficult,” says Elad Benjamin, Co-founder and CEO of Zebra Medical Vision. “We are making a commitment to provide our current tools, and all future ones, for a flat $1 USD per scan. By doing so we believe that a true difference can be made in the provision of radiology services worldwide.”
For more information about the availability of the solution in your country or integrating Zebra Medical Vision’s Engine into your hospital or practice, please visit https://www.zebra-med.com/ai1.
About Zebra Medical Vision:
Zebra Medical Vision uses artificial intelligence and deep learning to create and provide next generation products and services to the healthcare industry. Its Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease, and offer improved, preventative treatment pathways to improve patient care. AI1 is the company’s commitment to make AI-enabled healthcare solutions affordable globally, including its current and future algorithms available for a low flat price per scan. The company has been named a Top 5 global AI company (FastCompany) , Top 50 AI Leader (Fortune) , Cool Vendor (Gartner) and has won the Social Impact Award by Nvidia. Headquartered in Israel, the company was founded in 2014 by Eyal Gura, Eyal Toledano, and Elad Benjamin and is funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd, and Dolby Ventures. For more information visit https://www.zebra-med.com.
